Physicians
J&J axes eye disease gene therapy after key phase 2b readout
- Johnson & Johnson has stopped development of an eye disease gene therapy after reviewing data from one of its key readouts for 2026.
Issue №064 · 2026-07-17
Daily Briefing · Issue №064 · 2026-07-17
Health OS
West Tennessee Healthcare expands critical care support through eICU Program in partnership with Philips and h
- Jackson, TN - West Tennessee Healthcare is continuing to strengthen critical care services across the region through the expansion of its systemwide eICU program powered by Philips eCareManager and integrated with the he
Health OS
OpenAI’s health AI chief: ‘Bet on the models getting better’
- Fierce Healthcare Executive Editor Heather Landi speaks with Karan Singhal, OpenAI’s health AI chief, about how the company is improving its health capabilities, working with physicians to evaluate model performance and